CSI Market
Sign In | Register

Guardion Health Sciences Inc (GHSI) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access GHSI Annual Income Statement →
The income statement data below highlights shifts in Guardion Health Sciences Inc's operating performance over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2024)
Q2 2024 		(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax0.07
Total Revenue0.07
Costs & Expenses
Cost of Goods and Services Sold0.04
Gross Profit0.04
Selling, Administration, Marketing0.01
Depreciation & Amortization0.00
Research and Development Expense0.00
Business Combination, Acquisition Related Costs0.00
Other Operating Expense / -Income1.40
Total operating costs including COS1.45
Operating income / -loss-1.38
Interest Income-0.12
Net Interest (-)Expense / Income0.12
Loss / -Gain on Investment12.74
Other loss / -income0.32
Total costs & expenses2.21
Income & Taxes
Income / -loss before income taxes-2.13
Income after income taxes-2.13
Net income / -loss of other equity-12.94
Income / -loss from continuing operations-15.08
Discontinued operations25.40
Net income / -loss10.32
Income / -loss to shareholder10.32
EBIT-2.25
EBITD-2.25
EBITDA-2.25
Earnings Per Share
Basic EPS (excl. extra items)-1.66
Extraordinary items9.70
Basic Net EPS8.04
Basic shares outstanding (Mill. of Units)1.28
Diluted Net EPS7.96
Diluted average shares (Mill. of Units)1.30
4 historic quarters locked

Sign in to unlock the full Guardion Health Sciences Inc income statement history.

Sign In Create Free Account

About Guardion Health Sciences Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: August 13, 2024
  • Original filing: form10-q.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.